Last Week’s Top-3 Most Read Posts On Multiple Sclerosis


Read the Articles Here:

Novartis’ MS Drug Gilenya Prevents Activation of Key Immune Cells in Study

Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results

Could Remyelination Be Achieved in MS Using an Anti-Inflammatory Treatment?

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This